openPR Logo
Press release

Monogenetic Disease Therapy Market:Future Scope, Demands and Projected Industry Growths to 2025

01-15-2020 10:36 AM CET | Health & Medicine

Press release from: Kenneth Research

Monogenetic Disease Therapy Market:Future Scope, Demands

Monogenetic Disease Therapy Market: Introduction

Monogenetic diseases result from the mutation or change in the DNA sequence of one gene. A mutated gene hinders the normal functioning of the protein present in its composition and hence results in various types of monogenetic disorders such as cystic fibrosis, sickle cell disease, Gaucher disease, SCID and others.

The monogenetic disease therapy market is expected to grow during the forecast period, due to a rise in the incidence of monogenetic diseases, coupled with advancement in treatment technologies.

Market Dynamics:

The monogenetic disease therapy market is expected to grow during the forecast period, due to the rising prevalence of monogenetic diseases globally. According to the World Health Organization (WHO), the global prevalence of all monogenetic diseases at birth is approximately 10/1000. Increased research activities and clinical trials on monogenic diseases and its therapeutic treatments are further anticipated to drive the monogenetic diseases therapy market.

According to NCBI, monogenetic diseases were the second most popular indication of gene therapies after cancer, accounted for 10% of the total gene therapy trials conducted between 1989 and 2015.

Other driving factors for the growth of monogenetic disease therapy market include rising awareness towards genetic diseases, coupled with the presence of key healthcare market players such as Sanofi, Bayer AG, Pfizer Inc., and others who are determined to develop innovative therapies, advanced bio-instruments, and vaccines to treat monogenetic diseases.

Request To Download Sample of This Strategic Report: https://www.kennethresearch.com/sample-request-10220969

However, high therapy cost and lower commercial success rates of treatments like gene therapy can restrain the growth of global monogenetic disease therapy market.

By Inheritance Pattern

On the basis of inheritance pattern, autosomal monogenetic diseases therapy market is expected to grow at a faster pace, due to rise in a number of autosomal monogenetic diseases like Cystic fibrosis (a most common type of monogenetic disease), Tay Sachs disease and Sickle cell anemia.

According to the European Lung White Book, one in 25 people of European descent carries one mutant allele of CFTR, and one person among 2000-3000 people is affected by cystic fibrosis. Chromosomal disease therapy is also expected to grow during the forecast period, owing to the rising incidence of hemophilia, hunter disease, and others. Haemophilia is estimated to be afflicted in 1 in 10,000 people globally.

By Therapy Type

Pharmacological and surgical therapies for treating monogenetic diseases are predicted to dominate the global market, due to their higher preference among patients. For instance, in February 2018, the U.S. FDA approved a combination of ivacaftor and tezacaftor, developed by Vertex Pharmaceutical, to treat cystic fibrosis. Gene therapy is another therapy segment which is expected to witness a rapid growth over the forecast period, owing to its efficiency in the treatment of monogenetic diseases like CF and SCID.

For instance, Glybera, which is the first clinically approved gene therapy in the European Union, uses an adeno-associated virus (AAV) vector drug for correction of lipoprotein lipase deficiency and to correct cystic fibrosis, it uses repeated nebulization of liposomes encoding the cystic fibrosis transmembrane conductance regulator (CFTR).

Competitive Landscape

Key market players operating in global monogenetic disease therapy market include Abbott Laboratories, BAG Healthcare Gmbh, Novartis, Pfizer Inc., Vertex Pharmaceuticals, Bristol-Myers Squibb, F. Hoffmann-La Roche Limited, Bayer AG, Grifols S.A, Bluebird Bio, UniQure, and Sanofi S.A.

Market players, clinical research organizations and hospitals are focusing on collaborations to develop and commercialize therapies for the treatment of monogenetic diseases.

Read More:- https://www.kennethresearch.com/report-details/monogenetic-disease-therapy-market/10220969

For instance, in August 2018, Mustang Bio, a U.S. based pharmaceutical firm entered into an exclusive license agreement with St. Jude Children’s Research Hospital to develop the ex-vivo lentiviral gene therapy for X-linked SCID (commonly known as Bubble Boy Disease) treatment. Through this merger, Mustang Bio aims to expand their pipeline into gene therapy for patients with X-SCID.

Contact Us:-
Name: David
Email : Sales@kennethresearch.com
Phone: +1 313 462 0609

About Kenneth Research:-
Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Monogenetic Disease Therapy Market:Future Scope, Demands and Projected Industry Growths to 2025 here

News-ID: 1896641 • Views: 114

More Releases from Kenneth Research

Distributed Energy Resource Management System Market Outlook and Growth Stance F …
The Global Distributed Energy Resource Management System Market was valued at USD 258.32 million in 2016 and is projected to reach USD 961.99 million by 2025, growing at a CAGR of 15.73% from 2017 to 2025. Distributed Energy Resources are electricity generation units located within an electricity distribution system at or near the end user. Distributed Energy Resources management system (DERMS) keeps the grid balanced and optimized in real-time and maintains
Recent Business Report On Coding Bootcamp Market By Major Key Vendors 2018-2025
Global Coding Bootcamp Market Analysis According to Verified Market Research, the Global Coding Bootcamp Market growing at a CAGR of 10.96% from 2018 to 2025. What is Coding Bootcamp? A coding bootcamp is type of training program that is involved in teaching programing skills to the seeking employers. The training session can range from few weeks to few months. These coding bootcamps are beneficial for improving programming skills and enhancing the prospects of
U.S. Financial Services Cyber Security Market Generates Huge Revenue Till 2020 …
This cyber security market report focuses on the U.S. financial services demand side of cyber security products, systems & services. It is based on hundreds of interviews with financial institutions’ cyber security customers, CEOs, CISOs and CIOs as well as cyber security industry executives and world-class experts. The surge and sophistication of “successful” cyber crimes against the U.S. financial services enterprises, major retail chains, and banks during 2013-2015, when over 600
Recent Business Report On South East Asia Clear Aligner Market By Major Key Vend …
Executive Summary South East Asia Clear Aligner Market was valued at USD 47.78 Million in the year 2018. With presence of economies including Vietnam, Philippines, Cambodia, Singapore, Malaysia, Thailand that are witnessing strong economic growth and resilient domestic demand coupled with high infrastructure spending and execution of various structural economic reforms in economies such as Indonesia and Philippines, has been estimated to accelerate the Clear Aligner Market Growth in the region

All 5 Releases


More Releases for Monogenetic

Monogenetic Disorders testing Market Emerging Trends and Top Key Players to Watc …
According to Mendel's Laws, the monogenetic disorders are inherited because of a single defective gene on the autosomes. The monogenic disorders are caused by single mutated gene which can be present on single or both chromosomes. Females and males are equally affected by this disorder due to the conditions on the autosomes. Some of the tests are available for the mainstream of the common monogenic disorders such as Cystic fibrosis,
Nucleic acid-based therapeutics Market Opportunity with New Innovations, Applica …
Market Overview Nucleic acid-based therapeutics are target deficiencies or dysfunctions at the molecular level and are targeted therapies. These are used specifically to target genetic diseases and disorders for which there exists no permanent cure such as thalassemia, sickle cell anemia, hemophilia, cystic fibrosis, diabetes etc. The nucleic acid-based therapeutics are based on accurate target identification and genetic profiling and the human gene project has formed the backbone of these class of
Nucleic Acid-based Therapeutics Market Worldwide Trend and Healthy Evolving Grow …
Global Nucleic Acid-based Therapeutics Market Information by Applications Monogenetic disorders Cancer, Diabetes, Neurodegenerative Diseases, cardiovascular Diseases etc. and by End Users Hospitals, Academic & Research Institutes - Forecast till 2022 Nucleic Acid-based Therapeutics Market Segments: Global nucleic acid-based therapeutics market has been segmented on the basis of technology which comprises anti-sense and anti-gene, short inhibitory sequences, gene transfer therapy, nucleoside analogs, ribozymes, aptamers and others. On the basis of applications; market is
Recent Research: Monogenetic Disorders Testing Market Analysis to 2025
According to Mendel’s Laws, the monogenetic disorders are inherited because of a single defective gene on the autosomes. The monogenic disorders are caused by single mutated gene which can be present on single or both chromosomes. Females and males are equally affected by this disorder due to the conditions on the autosomes. Request Report for TOC @ https://www.persistencemarketresearch.com/toc/18691 Some of the tests are available for the mainstream of the common
Monogenetic Disorders testing Market to Record Sturdy Growth by 2025
According to Mendel's Laws, the monogenetic disorders are inherited because of a single defective gene on the autosomes. The monogenic disorders are caused by single mutated gene which can be present on single or both chromosomes. Females and males are equally affected by this disorder due to the conditions on the autosomes. Some of the tests are available for the mainstream of the common monogenic disorders such as Cystic fibrosis,
Cancer Gene Therapy Market Sales Revenue Opportunity Report
The gene therapy market has undergone series of transformation from the initial days of research to current clinical development of drugs for treatment of multiple diseases. The initial studies of gene therapy were conducted mostly on monogenetic diseases, but the focus of the researchers rapidly shifted towards the cancer. The increasing popularity of cancer therapeutics as a major interest for gene therapy applications led to it accounting for a dominant